Rights issue in Isofol Medical AB (SE) — SEK 150 million Healthcare Rights issue in Isofol Medical AB (SE) — SEK 150 million
Rights issue of units in Catena Media AB (SE) — SEK 684 million TMT Rights issue of units in Catena Media AB (SE) — SEK 684 million
Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million Business Services Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million
Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million Healthcare Directed share issue in Faron Pharmaceuticals Oy (FI) – EUR 14.0 million
Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million TMT Directed new share issue in Enad Global 7 AB (SE) – SEK 119 million
Directed share issue in Embracer Group AB (SE) — SEK 1.6 billion TMT Directed share issue in Embracer Group AB (SE) — SEK 1.6 billion
Directed share issue in Sinch AB (SE) — SEK 1.5 billion TMT Directed share issue in Sinch AB (SE) — SEK 1.5 billion
Acquisition of a portfolio of 43 public use properties and financing in Mälardalens Omsorgsfastigheter Holding AB (publ) – Underlying property value of SEK 842 million Real Estate Acquisition of a portfolio of 43 public use properties and financing in Mälardalens Omsorgsfastigheter Holding AB (publ) – Underlying property value of SEK 842 million
Rights issue in IRRAS AB (SE) — SEK 217 million Healthcare Rights issue in IRRAS AB (SE) — SEK 217 million
Rights issue in Bambuser AB (SE) — SEK 101 million TMT Rights issue in Bambuser AB (SE) — SEK 101 million
Private placement of shares in Cinclus Pharma Holding AB (SE) — SEK 250 million Healthcare Private placement of shares in Cinclus Pharma Holding AB (SE) — SEK 250 million
Directed new share issue in IRLAB Therapeutics AB (SE) — SEK 215 million Healthcare Directed new share issue in IRLAB Therapeutics AB (SE) — SEK 215 million